Клиническое исследование

CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation

NCT: NCT07857343 · NOT_YET_RECRUITING

NCT IDNCT07857343

СтатусNOT_YET_RECRUITING

Дата начала2026-12-01

Завершение2035-01-01

SponsorShanghai MicroPort CardioFlow Medtech Co., Ltd. (INDUSTRY)

First posted2026-10-05

Last updated2026-10-05

Краткое описание

This is a prospective, multi-center, single-arm study to assess the safety and effectiveness of Microport CardioFlow Transcatheter Mitral Valve Replacement system in the treatment of moderate to severe or severe degenerative mitral regurgitation and to provide the clinical evidence for product registration in China or other countries

Официальный источник

Открыть на ClinicalTrials.gov →

Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.